Factor V Leiden: Is it the chief contributor to activated protein C resistance in Asian-Indian patients with deep vein thrombosis?

Clinica Chimica Acta

Volumn 392, Issue 1-2, 2008, Pages 21-24

  Biswas, Arijit ^a   Bajaj, Jyoti ^a   Ranjan, Ravi ^a   Meena, Arvind ^a   Akhter, Mohd Suhail ^a   Yadav, Birendra Kumar ^a   Sharma, Vinita ^a   Saxena, Renu ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Activated protein C resistance; Deep vein thrombosis; Factor V Hong Kong Cambridge; Factor V Leiden; HR2 Haplotype

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN;

ACTIVATED PROTEIN C RESISTANCE; ADULT; ARTICLE; ASIAN; CAUCASIAN; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DISEASE ASSOCIATION; FEMALE; GENE MUTATION; HAPLOTYPE; HEREDITY; HUMAN; INDIAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT;

ACTIVATED PROTEIN C RESISTANCE; ADOLESCENT; ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; CHILD; CHILD, PRESCHOOL; FACTOR V; GENOTYPE; HUMANS; INDIA; MIDDLE AGED; MUTATION; VENOUS THROMBOSIS;

EID: 42749088081     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2008.02.018     Document Type: Article

References (22)

1. Kalafatis M., Bertina R.M., Rand M.D., and Mann K.G. Characterization of the molecular defect in factor VR506Q. J Biol Chem 270 (1995) 4053-4057
2. Nicolaes G.A., Tans G., Thomassen M.C., et al. Peptide bond cleavages and loss of functional activity during inactivation of factor Va and factor VaR506Q by activated protein C. J Biol Chem 270 (1995) 21158-21166
3. Varadi K., Rosing J., Tans G., Pabinger I., Keil B., and Schwarz H.P. Factor V enhances the cofactor function of protein S in the APC-mediated inactivation of factor VIII: influence of the factor VR506Q mutation. Thromb Haemost 76 (1996) 208-214
4. Thorelli E., Kaufman R.J., and Dahlback B. Cleavage of Factor V at Arg 506 by activated protein C and the expression of anticoagulant activity of factor V. Blood 93 (1999) 2552-2558
5. Rosendaal F.R., Koster T., Vandenbroucke J.P., and Reitsma P.H. High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance). Blood 85 (1995) 1504-1508
6. Lindqvist P.G., Svensson P., and Dahlbäck B. Activated protein C resistance - in the absence of factor V Leiden - and pregnancy. J Thromb Haemost 4 (2006) 361-366
7. Bauduer F., and Lacombe D. Factor V Leiden, prothrombin 20210A, methylenetetrahydrofolate reductase 677T, and population genetics. Mol Genet Metab 86 (2005) 91-99
8. Gupta P.K., Ahmed R.P., Bhattacharyya M., et al. Protein C system defects in Indian children with thrombosis. Ann Hematol 84 (2005) 85-88
9. Ahmed R.P., Gupta P.K., Kannan M., Choudhry V.P., and Saxena R. Factor V Leiden-the commonest molecular defect in arterial and venous thrombophilia in India. Thromb Res 110 (2003) 19-21
10. Williamson D., Brown K., Luddington R., and Baglin C. Factor V Cambridge. A new mutation (Arg306 to Thr) associated with resistance to activated protein C. Blood 91 (1998) 1140
11. Chan W.P., Lee C.K., Kwong Y.L., Lam C.K., and Liang R. A novel mutation of Arg306 of factor V gene in Hong Kong Chinese. Blood 91 (1998) 1135
12. Bernardi F., Faioni E.M., Castoldi E., et al. A factor V genetic component differing from factor V R506Q contributes to the activated protein C resistance phenotype. Blood 90 (1997) 1552-1557
13. Lunghi B., Iacoviello L., Gemmati D., et al. Detection of new polymorphic markers in the factor V gene: association with factor V levels in plasma. Thromb Haemost 75 (1996) 45-48
14. Castoldi E., Rosing J., Girelli D., et al. Mutations in the R2 Factor V gene affects the ratio between the two Factor V isoforms in plasma. Thromb Haemost 83 (2000) 362-365
15. Pepe G., Rickards O., Vanegas O.C., et al. Prevalence of factor V Leiden mutation in non-European populations. Thromb Haemost 77 (1997) 329-331
16. Cushman M. Inherited risk factors for venous thrombosis. Hematol Am Soc Hematol Educ Program (2005) 452-457
17. Van Cott E.M., Soderberg B.L., and Laposata M. Activated protein C resistance, the factor V Leiden mutation, and a laboratory testing algorithm. Arch Pathol Lab Med 126 (2002) 577-582
18. Hiyoshi M., Hashimoto S., Tagawa S., Arnutti P., Prayoonwiwat W., and Tatsumi N. A Thai patient with the mutation of Arg306 of Factor V gene identical to the Hong Kong but not to the Cambridge type. Thromb Haemost 82 (1999) 1553-1554
19. Chan W.P., Lee C.K., Kwong Y.L., Lam C.K., and Liang R. A novel mutation of Arg306 of factor V gene in Hong Kong Chinese. Blood 91 (1998) 1135-1139
20. van der Neut Kolfschoten M., Dirven R.J., Vos H.L., Tans G., Rosing J., and Bertina R.M. Factor Va is inactivated by activated protein C in the absence of cleavage sites at Arg-306, Arg-506, and Arg-679. J Biol Chem 279 (2004) 6567-6575
21. Undas A., Williams E.B., Butenas S., Orfeo T., and Mann K.G. Homocysteine inhibits inactivation of factor Va by activated protein C. J Biol Chem 276 (2001) 4389-4397
22. Graf L.L., Welsh C.H., Qamar Z., and Marlar R.A. Activated protein C resistance assay detects thrombotic risk factors other than factor V Leiden. Am J Clin Pathol 119 (2003) 52-60